Reply to Del Gaizo et al.'s “The SPOT GRADE: A Clinically Validated, Quantitative Bleeding Severity Scale”
![Table V from Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents | Semantic Scholar Table V from Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/60a04b9bd7c6992a491cdafd41562e8f84f6e23f/8-TableV-1.png)
Table V from Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents | Semantic Scholar
![Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents | Baxter specialty Site Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents | Baxter specialty Site](https://advancedsurgery.baxteritalia.it/sites/g/files/ebysai2941/files/styles/portrait_image/public/2019-01/VIBeSCALE%20Paper.jpg?itok=TsRq8m54)
Development and validation of an intraoperative bleeding severity scale for use in clinical studies of hemostatic agents | Baxter specialty Site
![Full article: Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia Full article: Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia](https://www.tandfonline.com/cms/asset/a92c3f5f-362b-4221-b2c6-04a3adca8d1b/icmo_a_644849_f0002_b.jpg)
Full article: Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia
![Clinical Decision-Making When Treating High Bleeding Risk Patients: A Japanese Perspective - Cardiac Interventions Today Clinical Decision-Making When Treating High Bleeding Risk Patients: A Japanese Perspective - Cardiac Interventions Today](http://citoday.com/images/articles/2019-05/0519_Supp3_Table1.png)
Clinical Decision-Making When Treating High Bleeding Risk Patients: A Japanese Perspective - Cardiac Interventions Today
![Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. | Semantic Scholar Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf0e93f8114f3e27e6bc3b1c59b7c7f0af3896da/2-Table1-1.png)
Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count. | Semantic Scholar
![Development and implementation of a novel immune thrombocytopenia bleeding score for dogs | Semantic Scholar Development and implementation of a novel immune thrombocytopenia bleeding score for dogs | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/175e768a7f5f976f2c696c4c050503e646c5c665/2-Table1-1.png)
Development and implementation of a novel immune thrombocytopenia bleeding score for dogs | Semantic Scholar
![Aaron Logan, MD, PhD, MPhil on X: "#ASH20 Gernsheimer: Subjects were assess by WHO bleeding scale and self-reporting. No difference in WHO gr2 bleeding events in the two groups. https://t.co/cxFvhvgN6u" / X Aaron Logan, MD, PhD, MPhil on X: "#ASH20 Gernsheimer: Subjects were assess by WHO bleeding scale and self-reporting. No difference in WHO gr2 bleeding events in the two groups. https://t.co/cxFvhvgN6u" / X](https://pbs.twimg.com/media/EokH6CoU8AA9gjF.png)